Skip to main content

Clinical Trials Using Denosumab

Review the clinical trials studying denosumab on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-3 of 3

Zunsemetinib in Combination with Capecitabine for the Treatment of Patients with Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer
Status: Active
Location: Siteman Cancer Center at Washington University, Saint Louis, Missouri
Zanzalintinib with Bone-Strengthening Agents for Treating Clear Cell Renal Cell Cancer Patients with Bone Metastases
Status: Approved
Location: University of California San Francisco, San Francisco, California
Response of Bone Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers with Actionable Driver Mutations
Status: Active
Location: 2 locations